Recognizing Toxidromes: Key Symptoms in Poisoning

Poisonings are among those situations in emergency medicine where recognizing clinical patterns is immediately decisive for therapy. Reliable history is often unavailable – patients are unconscious, uncooperative, or collateral information is contradictory. This is precisely where the concept of toxidromes comes in: recurring symptom constellations that point to specific substance classes and enable you to initiate targeted therapy before toxicological lab results are available. Systematic knowledge of the four major toxidromes – cholinergic, anticholinergic, sympathomimetic, and opioid syndrome – is indispensable for every emergency physician and can make the difference between targeted antidote administration and valuable time lost.

The Concept of Toxidromes

A toxidrome (from "toxic" and "syndrome") refers to a characteristic cluster of vital signs, pupillary changes, skin findings, level of consciousness, and other clinical signs caused by a specific substance class. The clinical examination follows a structured approach:

• Vital signs: Heart rate, blood pressure, respiratory rate, temperature
• Pupils: Miosis vs. mydriasis, light reaction
• Skin: Dry vs. moist, color, temperature
• Mucous membranes: Dry vs. moist
• Bowel sounds: Increased vs. decreased/absent
• Consciousness: Agitation vs. somnolence/coma
• Muscle tone: Flaccid vs. increased, fasciculations

In most cases, these parameters are sufficient to identify one of the classic toxidromes and initiate rational initial therapy. The key is that you perform this examination systematically and completely – individual findings are often nonspecific; only the pattern points the way.

Cholinergic Toxidrome

Pathophysiology

The cholinergic toxidrome results from overactivation of muscarinic and nicotinic acetylcholine receptors. Classic triggers include:

• Organophosphates and carbamates (pesticides, nerve agents)
• Cholinesterase inhibitors (neostigmine, physostigmine in overdose)
• Certain mushroom toxins (muscarine-containing mushrooms such as Inocybe and Clitocybe species)

Organophosphates inhibit acetylcholinesterase irreversibly, carbamates reversibly. In both cases, acetylcholine accumulates at muscarinic and nicotinic synapses.

Key Symptoms

The muscarinic symptoms can be remembered using the mnemonics SLUDGE or DUMBELS:

• Salivation
• Lacrimation
• Urination
• Defecation
• Gastrointestinal cramps
• Emesis

Additionally with DUMBELS: Bronchospasm and Bronchorrhea as well as Miosis.

Nicotinic symptoms include:

• Muscle fasciculations
• Muscle cramps, weakness progressing to paralysis
• Tachycardia (in contrast to muscarinic bradycardia)
• Hypertension

The life-threatening triad consists of bronchorrhea, bronchospasm, and respiratory failure – patients ultimately "drown" in their own secretions.

Treatment

• Immediate measure: Personal safety first! Remove contaminated clothing, wear gloves. With organophosphates, there is a risk of contamination.
• Atropine: The central antidote against muscarinic symptoms.
  • Initial dose: 1–3 mg IV in adults
  • If response is inadequate: double the dose every 3–5 minutes
  • Target endpoint: drying of bronchial secretions (not pupil size!)
  • In severe organophosphate poisoning, total doses of 20–100 mg or more may be required
• Obidoxime (or pralidoxime): Acetylcholinesterase reactivator
  • Obidoxime: 250 mg IV bolus, then 750 mg/24 h via continuous infusion
  • Only effective before phosphorylation of cholinesterase "ages" (becomes irreversible) – time window is substance-dependent
  • Not indicated in carbamate poisoning
• Benzodiazepines: For seizures, diazepam 5–10 mg IV or midazolam 5 mg IV
• Airway management: Intubate early in cases of massive bronchorrhea. Avoid succinylcholine (not metabolized due to inhibited cholinesterase).

Anticholinergic Toxidrome

Pathophysiology

The anticholinergic (antimuscarinic) toxidrome is essentially the mirror image of the cholinergic toxidrome. It results from blockade of muscarinic acetylcholine receptors. Common triggers:

• Atropine, scopolamine
• Antihistamines (diphenhydramine, promethazine)
• Tricyclic antidepressants (amitriptyline, doxepin)
• Phenothiazines
• Deadly nightshade (Atropa belladonna), angel's trumpet (Brugmansia), jimsonweed (Datura stramonium)

Key Symptoms

The classic mnemonic is: "Blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone, full as a flask."

Translated into clinical findings:

• Mydriasis with absent or sluggish light reaction
• Agitation, confusion, hallucinations, delirium progressing to seizures
• Skin flushing (peripheral vasodilation)
• Hyperthermia (absent sweat secretion!)
• Dry skin and mucous membranes
• Urinary retention, decreased bowel sounds progressing to ileus
• Tachycardia

Particularly treacherous: With tricyclic antidepressants, anticholinergic symptoms overlap with sodium channel blocking effects (QRS widening) and alpha-adrenergic blockade (hypotension), making the toxidrome more complex.

Treatment

• Physostigmine: The specific antidote – a reversible cholinesterase inhibitor that crosses the blood-brain barrier.
  • Dose: 0.5–2 mg IV slowly over 5 minutes
  • Onset of action within minutes
  • Cave: Contraindicated when QRS duration >120 ms (TCA intoxication with sodium channel blockade), in AV block, and in seizures
  • Close monitoring required, note the short half-life (repeat dosing possible)
• Benzodiazepines: First-line treatment for agitation and seizures (midazolam 5 mg IV or diazepam 5–10 mg IV)
• Active cooling: For hyperthermia, use physical cooling measures; no antipyretics (ineffective centrally)
• Sodium bicarbonate: For TCA intoxication with QRS widening, 1–2 mmol/kg IV bolus, target pH 7.45–7.55
• No forced gastric emptying in anticholinergic motility disorder – activated charcoal only if ingestion was recent and the airway is protected

Sympathomimetic Toxidrome

Pathophysiology

The sympathomimetic toxidrome results from excessive activation of the sympathetic nervous system through catecholamine release or reuptake inhibition. Typical triggers:

• Cocaine
• Amphetamines, methamphetamine, MDMA (ecstasy)
• Synthetic cathinones ("bath salts")
• Adrenergic substances (ephedrine, pseudoephedrine in overdose)
• Theophylline, caffeine (in very high doses)

Key Symptoms

• Tachycardia and hypertension (cave: coronary vasoconstriction with cocaine!)
• Mydriasis (distinction from anticholinergic syndrome: skin is moist and diaphoretic!)
• Hyperthermia – potentially life-threatening (with MDMA or methamphetamine, temperatures >40 °C can occur)
• Agitation, psychosis, paranoia
• Diaphoresis (profuse sweating – THE key distinguishing feature from anticholinergic toxidrome)
• Tremor, hyperreflexia, seizures
• Rhabdomyolysis as a feared complication

Differentiation from the Anticholinergic Toxidrome

This point deserves special attention, as both toxidromes present with mydriasis, tachycardia, and agitation. The decisive distinction:

Finding	Sympathomimetic	Anticholinergic
Skin	Moist, diaphoretic	Dry
Bowel sounds	Normal to increased	Decreased/absent
Bladder	Normal	Urinary retention
Mucous membranes	Moist	Dry

Treatment

• Benzodiazepines: Cornerstone of therapy! They address agitation, hypertension, tachycardia, and seizure tendency simultaneously.
  • Diazepam 5–10 mg IV, repeat as needed
  • Midazolam 5–10 mg IV or IM
  • Dose generously – sympathomimetic-intoxicated patients may require high doses
• No beta-blockers in cocaine intoxication: There is a risk of unopposed alpha-stimulation with paradoxical hypertension and coronary vasospasm. For refractory hypertension: phentolamine 2.5–5 mg IV or nitroprusside.
• Nitroglycerin: Drug of choice for cocaine-induced angina pectoris.
• Active cooling: For hyperthermia >39 °C, aggressive physical cooling (ice packs, cold infusions). Dantrolene has no established role.
• Volume resuscitation: Liberal crystalloid infusions (rhabdomyolysis prophylaxis, dehydration).
• CK monitoring and urine alkalinization for rhabdomyolysis.

Opioid Toxidrome

Pathophysiology

The opioid toxidrome results from activation of µ-opioid receptors in the central and peripheral nervous system. Beyond classic opioids such as morphine and heroin, the proliferation of highly potent synthetic opioids (fentanyl, carfentanil) has massively increased the clinical significance of this toxidrome. Triggers:

• Heroin, morphine, codeine
• Fentanyl and analogs (including transdermal)
• Methadone, buprenorphine
• Oxycodone, hydromorphone, tramadol

Key Symptoms

The classic triad:

1. Altered consciousness (somnolence to deep coma)
2. Respiratory depression (bradypnea <8/min to apnea)
3. Miosis (bilateral, pinpoint pupils)

Additional findings:

• Hypotension, bradycardia
• Hypothermia
• Decreased bowel sounds
• Muscular hypotonia, areflexia
• Pulmonary edema (noncardiogenic, especially in heroin intoxication)

Cave: In mixed intoxication with anticholinergic substances, pupils may be normal or even dilated – miosis is supportive, but its absence does not rule out opioid intoxication!

Treatment

• Airway management: Highest priority! Begin bag-valve-mask ventilation immediately.
• Naloxone: Specific opioid receptor antagonist
  • Intravenous: 0.04–0.4 mg initially, titrate in small increments (0.04 mg each)
  • Intranasal: 2–4 mg (as prefilled spray or via MAD)
  • Intramuscular: 0.4 mg when no IV access is available
  • Goal of titration: Restoration of adequate spontaneous breathing (RR >10/min), NOT full alertness – overdosed naloxone provokes acute withdrawal syndrome with agitation, vomiting (aspiration risk!), tachycardia, and potentially pulmonary edema
  • Note the half-life: Naloxone lasts 30–90 minutes, many opioids last significantly longer (methadone up to 36 h!). Therefore: repeat dosing or continuous infusion (e.g., 0.4–0.8 mg/h, adjusted to clinical effect)
  • If there is no response to 10 mg naloxone cumulatively: opioid intoxication is unlikely – reassess differential diagnoses
• Monitoring: At least 4–6 hours after the last naloxone dose for short-acting opioids. For long-acting opioids (methadone, extended-release preparations) significantly longer, possibly 24 hours or more.

Additional Toxidromes at a Glance

Beyond the four classic toxidromes, you should be familiar with the following:

• Serotonin syndrome: Triad of altered mental status, autonomic dysfunction (tachycardia, hyperthermia, diaphoresis), and neuromuscular symptoms (clonus, hyperreflexia, tremor). Triggers: SSRIs, MAO inhibitors, tramadol, linezolid in combination. Treatment: benzodiazepines, cyproheptadine 8–12 mg PO, active cooling.
• Sedative-hypnotic syndrome: Altered consciousness, respiratory depression, hypotension, normal or dilated pupils, hypothermia. Triggers: benzodiazepines, barbiturates, GHB. Antidote for pure benzodiazepine intoxication: flumazenil 0.2 mg IV, however cave in mixed intoxications and patients with seizure history.

Systematic Approach in Practice

When you encounter a patient with altered consciousness of unknown origin or suspected intoxication – whether prehospital or in the emergency department – the following approach is helpful:

1. ABCDE approach: Address life-threatening conditions first. Airway management before antidote administration.
2. Vital signs and pupils: These four findings – heart rate, blood pressure, temperature, pupil size – already narrow things down considerably.
3. Skin and mucous membranes: Moist or dry? This separates sympathomimetic from anticholinergic.
4. Assign the toxidrome: No single finding is pathognomonic – the pattern is decisive.
5. Consider an antidote: Only with clear identification and appropriate indication. When in doubt: supportive therapy and consultation with a poison control center (in Austria: Vergiftungsinformationszentrale, Tel. +43 1 406 43 43).
6. Decontamination: Activated charcoal (1 g/kg body weight) only with a secured or anticipated secured airway and ingestion within the last 1–2 hours.

Common Pitfalls

• Mixed intoxications: In practice, combinations are common and blur the clinical picture. A patient after a suicide attempt rarely takes only one substance.
• Age-related effects: In geriatric patients, subtherapeutic doses of anticholinergic medications are often sufficient to produce a full-blown toxidrome.
• Pupils as the sole criterion: Pupil size is a helpful but not sufficient finding. Pinpoint pupils are also seen in pontine infarction or clonidine intoxication.
• The flumazenil trap: Reflexive administration of flumazenil in unclear unconsciousness is potentially dangerous – in chronic benzodiazepine use or co-ingestion of proconvulsant substances (TCAs!), refractory seizures may result.
• Naloxone for buprenorphine: Buprenorphine has an extremely high receptor affinity. Standard doses of naloxone are often ineffective; doses of 10 mg or more may be necessary.

Practical Training

Toxidrome recognition thrives on practicing clinical patterns under time pressure. In structured simulation training, the identification of symptom patterns, antidote titration, and management of mixed intoxications can be practiced in a realistic setting – with immediate feedback and the opportunity to work through even rare scenarios multiple times. In the Emergency Physician Refresher Course by Simulation Tirol, exactly these toxicological emergency scenarios are covered in a hands-on format, so you gain those decisive seconds when it matters most.

---